Riskpilot← Back to searchSign inGet full accessDURAPHARMA ApS
APSBankruptCVR 29916055Stationsvej 25Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20061 employees
Revenue 2018
DKK -387K
-10% vs 2017
EBITDA margin
132.9%
+46% vs 2017
Equity ratio
-11592.1%
Financial strength
Net profit 2018
DKK -1,1M
+25% vs 2017
| Revenue | DKK -387K | -10% |
| EBITDA | DKK -514K | +46% |
| Net profit | DKK -1,1M | +25% |
| Total assets | DKK 83K | -72% |
| Equity | DKK -9,6M | -13% |
| Employees | — | — |
Legal name
DURAPHARMA ApS
CVR number
29916055
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
14. september 2006
Share capital
DKK 125.000
Employees
1
VAT registered
No
Audit selected
No
Last report
2018-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren.
Address
Stationsvej 25
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | -490 | -569 | -717 | -527 | -677 | -429 | -387 |
| Staff expenses | -44 | -30 | -28 | -27 | -524 | -529 | -127 |
| EBITDA | -534 | -628 | -748 | -557 | -1.201 | -958 | -514 |
| Depreciation & amort. | -127 | -0 | -0 | -0 | -46 | -62 | -62 |
| EBIT | -661 | -628 | -748 | -557 | -1.247 | -1.019 | -576 |
| Net financials | -188 | -186 | -236 | -296 | -388 | -479 | -552 |
| Profit before tax | -849 | -814 | -983 | -853 | -1.635 | -1.498 | -1.128 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -849 | -814 | -983 | -853 | -1.635 | -1.498 | -1.128 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
|---|---|---|---|---|---|---|---|
| Total assets | 141 | 113 | 133 | 124 | 338 | 295 | 83 |
| Equity | -2.657 | -3.470 | -4.454 | -5.307 | -6.942 | -8.440 | -9.568 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2.797 | 3.583 | 4.587 | 5.431 | 7.279 | 8.735 | 9.650 |
| Total debt | 2.797 | 3.583 | 4.587 | 5.431 | 7.279 | 8.735 | 9.650 |
EBITDA margin
-51388700.0%
This company
15.8%
Market median
-325245037% vs market
20122018
Equity ratio
-11592.1%
This company
38.2%
Market median
-30446% vs market
20122018
Return on equity
-112779700.0%
This company
18.4%
Market median
-612933252% vs market
20122018
Net profit margin
-112779700.0%
This company
8.1%
Market median
-1392342075% vs market
20122018
Asset turnover
-4.68×
This company
1.12×
Market median
-518% vs market
20122018
Debt / equity
1.01×
This company
0.62×
Market median
-63% vs market
20122018
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JW Management | Management | 2008 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2008 | — | — | |
| Board of Directors | 2008 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
SITEKINE ApS | Company | 100.0% | 100.0% | 2006 |
| Individual | 33.3% | 33.3% | 2006 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DURAPHARMA ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Winther | Management | 0 companies |
| Lone Rosager | Board of Directors | 0 companies |
| Anna Winther | Board of Directors | 0 companies |
| Ulla Ilse Larsen | Board of Directors | 0 companies |